AI maps the way to better heart ablation?

NCT ID NCT07621055

Recruiting now Disease control Sponsor: Volta Medical Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test an AI software called Volta AF-Xplorer II during catheter ablation for atrial fibrillation. About 150 adults will be treated in real-world clinics, and researchers will track how well the AI helps guide the procedure. The goal is to see if the AI improves safety and reduces the return of irregular heart rhythms over two years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Volta AF-Xplorer II AI software (used during cardiac mapping and catheter ablation)
What this could lead to: If successful, this could show that AI-assisted mapping improves outcomes for people with atrial fibrillation undergoing ablation, potentially reducing repeat procedures.
What could go wrong: This is an observational study without a control group, so results may not prove the AI is better than standard care. The software is already approved, so major breakthroughs are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMIAS, CARDIAC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac atrial fibrillation atrial tachycardia cardiac rhythm disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARRHYTHMIAS, CARDIAC ATRIAL ARRHYTHMIA ATRIAL FIBRILLATION

Contacts and locations

Locations

Centre Cardiologique du Nord
NOT_YET_RECRUITING

Saint-Denis, 93207, France
Clinique Rhéna
NOT_YET_RECRUITING

Strasbourg, 67000, France
Hôpital Saint-Joseph Marseille
RECRUITING

Marseille, 13008, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.